These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8260733)

  • 1. Pathophysiology of reflux oesophagitis and peptic ulcer.
    Gabryelewicz A
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):23-40. PubMed ID: 8260733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiopathology and diagnostic methods in esophagitis due to reflux].
    Jonard P; Coppens JP; Fiasse R
    Acta Chir Belg; 1989; 89(1):41-5. PubMed ID: 2655360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflux esophagitis. Diagnosis, pathophysiology, and management.
    Crump WJ
    Prim Care; 1988 Mar; 15(1):13-30. PubMed ID: 3043493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal use of acid-inhibitors in acid-related diseases. Physiological and physiopathological considerations with implications on therapeutic choice].
    Waldum HL
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):465-9. PubMed ID: 8465291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenogastric and non acid gastro-oesophageal reflux in patients with reflux oesophagitis.
    Mattioli S; Felice V; Pastina M; Pilotti V; D'Ovidio F; Bacchi ML; Gozzetti G
    Hepatogastroenterology; 1995; 42(4):360-6. PubMed ID: 8586369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limitations of current therapy in peptic ulcer disease.
    Salena BJ; Hunt RH
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal gastric acidity pattern in gastro-oesophageal reflux disease with or without oesophagitis.
    Sozzi M; Valentini M; Poletti M; Bertolissi E; Serraino D; Bovero E; De Iaco F
    Ital J Gastroenterol; 1995; 27(8):413-8. PubMed ID: 8775466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflux oesophagitis.
    Barbezat GO
    Br J Hosp Med; 1995 Dec 13-1996 Jan 16; 54(11):583-6. PubMed ID: 8925151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
    Oudkerk Pool M
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():13-6. PubMed ID: 18081644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux oesophagitis in Italy (Diomede project).
    Baldi F; Cavoli C; Solimando R; Bianco MA; Cipolletta L; Costamagna G; Passaretti S
    Dig Liver Dis; 2008 Jun; 40(6):405-11. PubMed ID: 18294931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of oesophageal mucosal defence.
    Sarosiek J; McCallum RW
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):701-17. PubMed ID: 11003804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaline intra-oesophageal pH and gastro-oesophageal reflux in patients with peptic oesophagitis.
    Penagini R; Yuen H; Misiewicz JJ; Bianchi PA
    Scand J Gastroenterol; 1988 Aug; 23(6):675-8. PubMed ID: 3175530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic measurement of oesophageal transmucosal potential difference in reflux oesophagitis.
    Collins BJ; McFarland RJ; Sloan JM; Love AH
    Gut; 1984 Oct; 25(10):1103-6. PubMed ID: 6479686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oesophagitis on proximal extent of gastro-oesophageal reflux.
    Emerenziani S; Cicala M; Zhang X; Ribolsi M; Caviglia R; Guarino MP; Sifrim D
    Neurogastroenterol Motil; 2007 Jun; 19(6):459-64. PubMed ID: 17564627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital admissions and primary care attendances for nonulcer dyspepsia, reflux oesophagitis and peptic ulcer in Scotland 1981-2004.
    Baron JH; Sonnenberg A
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):180-6. PubMed ID: 18301297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective.
    Orlando RC
    Am J Gastroenterol; 1996 Sep; 91(9):1692-6. PubMed ID: 8792683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.